Top Journalists
>
Maria Cohut

Maria Cohut

Feature Editor at Medical News Today

Contact this person
Email address
m*****@*******.comGet email address
Influence score
66
Phone
(XXX) XXX-XXXXGet mobile number
Location
United Kingdom
Languages
  • English
Covering topics
  • Health & Medicine
  • Marketing

View more media outlets and journalists by signing up to AI PR

View latest data and reach out all from one place
Sign up to AI PR Toolkit

Recent Articles

medicalnewstoday.com

ADHD linked to around 50% higher odds of gut problems, including IBS

ADHD is linked to strikingly heightened odds of developing a wide array of gastrointestinal issues, according to a recent review and meta-analysis.
medicalnewstoday.com

Sleep supplements: How does magnesium compare to melatonin?

People who struggle with may opt for taking a melatonin supplement but magnesium has also been gaining traction as a sleep supplement. Experts explain who each supplement is best for.
medicalnewstoday.com

PMOS: In what cases might GLP-1s aid treatment?

Two experts explain why GLP-1s might aid in the treatment of PMOS, who really benefits from this additional treatment, and who it may not be for.
medicalnewstoday.com

Fructose and ovarian cancer metastasis: Is there a link?

New preclinical research has made a key discovery regarding the spread of ovarian cancer after chemotherapy. Fructose may play a role, it found.
medicalnewstoday.com

Fructose and ovarian cancer metastasis: Is there a link?

New preclinical research has made a key discovery regarding the spread of ovarian cancer after chemotherapy. Fructose may play a role, it found.
medicalnewstoday.com

Lipfendra vs statins: How these cholesterol-lowering drugs compare

Recently, the FDA has approved an oral PCSK9 inhibitor, Lipfendra, for the treatment of high cholesterol. A cardiologist explains how it compares to statins, who this treatment is for, and why.
medicalnewstoday.com

Lipfendra vs statins: How these cholesterol-lowering drugs compare

Recently, the FDA has approved an oral PCSK9 inhibitor, Lipfendra, for the treatment of high cholesterol. A cardiologist explains how it compares to statins, who this treatment is for, and why.
medicalnewstoday.com

Speaking several languages protects the aging brain: Here's how

Bilinguals and multilinguals may stay younger for longer and have more agile brains. This Special Feature shows just how language proficiency protects the brain.
medicalnewstoday.com

Up to 5 coffees a day safe for heart health, says AHA: What coffee ...

Up to 5 cups of caffeinated coffee a day are safe for heart health, and may even have a protective effect in some instances, according to a new scientific statement from the AHA. Two experts weigh in on the findings.
medicalnewstoday.com

FDA approves first-of-its-kind cholesterol pill Lipfendra

The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
medicalnewstoday.com

FDA approves first-of-its-kind cholesterol pill Lipfendra

The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.